Patent Assignment
Reel/Frame 034052/0334
Assignment of Assignor's Interest
Recorded: 2014-10-28
Pages: 3
Assignor
SALIX PHARMACEUTICALS, LTD.
Executed: 2014-10-24
Assignee
DR. FALK PHARMA GMBH
LEINEWEBERSTRASSE 5, FREIBURG, D-79108, GERMANY
Covered Properties
(3)
Compositions and Methods for Treatment of Irritable Bowel Syndrome with 5-Aminosalicylate
Compositions and Methods for Treatment of Irritable Bowel Syndrome with 5-Aminosalicylate
Application:
61/649,268 →
Compositions and Methods for Treatment of Irritable Bowel Syndrome with 5-Aminosalicylate
Application:
61/682,154 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Jan 2, 2014
From: SALIX PHARMACEUTICALS, LTD.
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 031896/0752 →
Release of Security Interest
Apr 1, 2015
From: JEFFERIES FINANCE LLC
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 035353/0661 →
Security Agreement
Apr 2, 2015
From: GLYCYX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 035364/0396 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →